DalsnaFinance › Analyst accuracy › UBS › ABBV target

UBS’s $275 target on ABBV

ABBV AbbVie
$276 → $275 (-1%) by Oct 2027
Neutral · raises · said Oct 9, 2026 · 12-month default horizon
Open: judged on the close on Oct 9, 2027

The article this target came from

ABBV Maintains Neutral Rating -- Price Target Raised to $275

GuruFocus · Oct 9, 2026
The price target has been adjusted upward from $260 to $275, reflecting a 5.77% increase.

A fact about what UBS published, as reported by GuruFocus, not a recommendation from Dalsna Finance; UBS is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.